Please ensure Javascript is enabled for purposes of website accessibility
Cory Renauer

Cory Renauer


Cory is a long-term minded analyst focused on the Healthcare Sector. He genuinely enjoys cutting through the complexity to help everyday investors make better decisions.

Recent articles


Why ICU Medical Stock Is Jumping Today

A leading manufacturer of intravenous therapy solutions is about to get a lot bigger.


Why Pliant Therapeutics Stock Is Surging Today

A positive phase 2 clinical trial readout was a positive step in the right direction for this biotech start-up.


3 Biotech Stocks Wall Street Expects to Double Soon

All three stocks on this list can more than double your money according to investment bank analysts who cover them.


3 Biotech Stocks That Soared to New Heights Last Week

Find out what these industry favorites are doing to impress investors.


Why Impel NeuroPharma Stock Is Soaring Today

The company's nasal spray got a green light from the FDA to treat migraine headaches.


3 Healthcare Stocks Cathie Wood Loves Right Now

Here's why the founder and CEO of ARK Invest set her sights on these three healthcare stocks.


Here's Why Axsome Therapeutics Stock Is Surging Today

The company still doesn't have much to say about the FDA and its experimental new anti-depression drug.


3 Stocks Near Record Highs to Buy Now

Sometimes, the best stocks to buy are already moving steadily in the right direction.


Why RedHill Biopharma Stock Jumped on Tuesday

An analyst on Wall Street thinks the company's commercial and development pipeline has been underestimated.


Here's Why AC Immune Stock Is Surging Today

MIxed results for the company's Alzheimer's disease candidate are good enough for the market today.


3 High-Growth Stocks That Could Soar by 30% or Better According to Wall Street

There's a stock on this list analysts think can climb by around 47%, as soon as more investors come around to their way of seeing things.


3 Reasons to Buy Butterfly Networks Right Now

This tiny manufacturer of handheld ultrasound devices has an edge over the competition.


Why BeyondSpring Stock Is Soaring This Week

A lucrative partnership deal with a pharmaceutical giant in China bodes well for BeyondSpring's potential new blockbuster cancer drug.


Here's Why Ascendis Pharma Shares Are Surging Higher Today

Approval of the company's weekly growth hormone is making investors smile today.


Here's Why Cassava Sciences Is Having a Bad Day

The FDA received a citizen petition requesting a halt to clinical trials with the company's Alzheimer's disease candidate.


3 Unstoppable Healthcare Stocks to Buy Now

Find out why these companies are dominating in the niches they created.


Here's Why Theravance Biopharma Stock Is Tanking Today

The company's second clinical-trial flop in as many months isn't sitting well with investors.


2 Soaring Biotech Stocks With More Fuel in the Tank

These recent winners still have a long way to run.


4 Reasons I Just Bought Ocular Therapeutix Stock

This company's drug delivery technology just isn't getting the appreciation it deserves right now.


Why Fate Therapeutics Stock Is Sliding Today

The positive results the company announced after the bell yesterday didn't meet some lofty expectations.